Sanofi SA logo

Sanofi SA (SNW)

Market Open
14 Oct, 04:59 PM
€
71. 72
+0.05
+0.0698%
€
- Market Cap
- P/E Ratio
0.33% Div Yield
23 Volume
0 Eps
€ 71.67
Previous Close
Add Transaction
Day Range
70.22 71.72
Year Range
70.19 89.84
Want to track SNW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SNW trading today higher at €71.72, an increase of 0.0698% from yesterday's close, completing a monthly decrease of -2.5146% or -€1.85. Over the past 12 months, SNW stock lost -13.7047%.
SNW is not paying dividends to its shareholders.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -1.3867%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 12 different exchanges and in various currencies, with the primary listing on LSE (EUR).

SNW Chart

Sanofi SA (SNW) FAQ

What is the stock price today?

The current price is €71.72.

On which exchange is it traded?

Sanofi SA is listed on XDUS.

What is its stock symbol?

The ticker symbol is SNW.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.33%.

What is its market cap?

As of today, no market cap data is available.

Has Sanofi SA ever had a stock split?

No, there has never been a stock split.

Sanofi SA Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Adam Buchajski CEO
XDUS Exchange
FR0000120578 ISIN
Poland Country
88 Employees
5 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Sanofi SA is a prominent French multinational pharmaceutical and healthcare company based in Paris, recognized for its dedication to the research, development, manufacturing, and marketing of innovative medicines and vaccines. Established in 1973, the company has grown significantly through pivotal mergers, including those with Synthélabo in 1999 and Aventis in 2004, creating a global entity with a workforce exceeding 90,000 employees across 90 countries. Sanofi strategically focuses on seven major therapeutic areas: cardiovascular health, central nervous system disorders, diabetes care, internal medicine, oncology, thrombosis prevention, and vaccine development. Notably, it stands as the world's largest producer of vaccines through its subsidiary, Sanofi Pasteur, reinforcing its commitment to public health. The company maintains a strong emphasis on research and development, utilizing AI-driven methodologies to focus on immunology, neurology, diabetes innovation, and mRNA technologies, while managing a robust pipeline of 80 compounds in clinical development aimed at addressing unmet medical needs worldwide.

Products and Services

  • Prescription Drugs

    Sanofi’s portfolio includes leading prescription medications such as Dupixent, which is utilized for treating eczema and various autoimmune conditions, demonstrating significant advancements in dermatological and immunological therapies.

  • Lovenox

    This medication is essential for thrombosis management, serving as an anticoagulant that prevents and treats blood clots, playing a crucial role in patient care for at-risk populations.

  • Taxotere

    Used in cancer treatment, Taxotere is an important chemotherapy agent that assists in managing various cancer types, contributing to the broader oncology therapeutic landscape.

  • Treatments for Rare Diseases

    Sanofi provides specialized treatments for rare conditions, such as Gaucher's disease and hemophilia, reflecting its commitment to addressing the needs of patients with unique medical challenges.

  • Over-the-Counter Products

    The company also markets a range of over-the-counter products, including Allegra for allergy relief and IcyHot for pain management, making healthcare accessible beyond prescription needs.

  • Vaccines

    Through Sanofi Pasteur, the company is the largest vaccine producer globally, developing and manufacturing vaccines that protect against various infectious diseases, thus playing a pivotal role in global vaccination efforts.

Contact Information

Address: ul. Cisowa 11
Phone: 48 81 444 6480